Role for the transcriptional activator ZRF1 in early metastatic events in breast cancer progression and endocrine resistance

Breast cancer is one of the most common malignancies among women which is often treated with hormone therapy and chemotherapy. Despite the improvements in detection and treatment of breast cancer, the vast majority of breast cancer patients are diagnosed with metastatic disease either at the beginni...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaymak, Aysegül, Sayols, Sergi, Papadopoulou, Thaleia, Richly, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033359/
https://www.ncbi.nlm.nih.gov/pubmed/29983888
http://dx.doi.org/10.18632/oncotarget.25596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033359/
https://www.ncbi.nlm.nih.gov/pubmed/29983888
http://dx.doi.org/10.18632/oncotarget.25596

Ejemplares similares